COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network
Charlotte Lanièce Delaunay, Nuno Verdasca, Susana Monge, Lisa Domegan et autres
10 citationsInfluenza and Other Respiratory Viruses